학술논문
ATTRACT 1-PHASE III TRIAL OF CARBOPLATIN/PACLITAXEL (CP) WITH OR WITHOUT THE VASCULAR DISRUPTING AGENT ASA404 IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): FINAL EFFICACY AND QUALITY OF LIFE (QOL) RESULTS
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15561380